Issue 16, 2022

Accessing chiral 2,2-disubstituted morpholines via organocatalytic enantioselective chlorocycloetherification

Abstract

Chiral morpholine is an important scaffold in organic synthesis and a pharmacophore in medicinal chemistry. However, catalytic enantioselective procedures for the construction of morpholines remain sparse. We report herein a catalytic asymmetric halocyclization protocol to furnish morpholines containing a quaternary stereocenter using cinchona alkaloid-derived phthalazine as the catalyst. Various chlorinated 2,2-disubstituted morpholines are achieved from alkenol substrates in excellent yields and enantioselectivities under mild conditions.

Graphical abstract: Accessing chiral 2,2-disubstituted morpholines via organocatalytic enantioselective chlorocycloetherification

Supplementary files

Article information

Article type
Research Article
Submitted
16 Mar 2022
Accepted
24 Jun 2022
First published
25 Jun 2022

Org. Chem. Front., 2022,9, 4372-4378

Accessing chiral 2,2-disubstituted morpholines via organocatalytic enantioselective chlorocycloetherification

H. Zhong, T. Ding, Q. Guo, Z. Tian, P. Yu and X. Jiang, Org. Chem. Front., 2022, 9, 4372 DOI: 10.1039/D2QO00390B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements